Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

by Rebecca Biason,University of TorontoCredit: CC0 Public DomainPeople who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX),

Updated on: March 28,2024

Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

by Rebecca Biason,University of TorontoCredit: CC0 Public DomainPeople who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX),

Updated on:March 28,2024

Role of ECHO emphasized in management of rheumatic heart disease

by Elana GotkineIn a report from the American Society of Echocardiography, published in the Jan. 1 issue of theJournal of the American Society of Echocardiography, the authors emphasize the role

Updated on: June 17,2024

Role of ECHO emphasized in management of rheumatic heart disease

by Elana GotkineIn a report from the American Society of Echocardiography, published in the Jan. 1 issue of theJournal of the American Society of Echocardiography, the authors emphasize the role

Updated on:June 17,2024

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Updated on: April 10,2024

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Updated on:April 10,2024

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Updated on: June 01,2024

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Updated on:June 01,2024

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe

Updated on: April 20,2024

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe

Updated on:April 20,2024

Respiratory allergies: Newly discovered molecule plays a major role in triggering inflammation

byCNRSMicroscopic visualization of immune cells (in green) activated by the alarmins TL1A and interleukin-33 during the onset of allergic inflammation in the lungs. ILC2s immune cells produce la

Updated on: April 28,2024

Respiratory allergies: Newly discovered molecule plays a major role in triggering inflammation

byCNRSMicroscopic visualization of immune cells (in green) activated by the alarmins TL1A and interleukin-33 during the onset of allergic inflammation in the lungs. ILC2s immune cells produce la

Updated on:April 28,2024

Black patients with lupus have three times higher risk of stroke

by American College of RheumatologyCredit: CC0 Public DomainNew research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of i

Updated on: May 23,2024

Black patients with lupus have three times higher risk of stroke

by American College of RheumatologyCredit: CC0 Public DomainNew research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of i

Updated on:May 23,2024

COVID-19 can cause severe inflammation in the brain

by Albert Ludwigs University of FreiburgGraphical Abstract. Credit:Immunity(2021). DOI: 10.1016/j.immuni.2021.06.002Both during and after infection with the Coronavirus SARS-CoV-2, pa

Updated on: April 10,2024

COVID-19 can cause severe inflammation in the brain

by Albert Ludwigs University of FreiburgGraphical Abstract. Credit:Immunity(2021). DOI: 10.1016/j.immuni.2021.06.002Both during and after infection with the Coronavirus SARS-CoV-2, pa

Updated on:April 10,2024

Study establishes IL-24 as a critical factor for onset and progression of atopic dermatitis

by Higher Education PressIL-24, which is expressed in keratinocytes and induced by S. aureus infection, promotes atopic dermatitis-like inflammation by enhancing a type 2 immune response. Credit: Xinm

Updated on: September 04,2024

Study establishes IL-24 as a critical factor for onset and progression of atopic dermatitis

by Higher Education PressIL-24, which is expressed in keratinocytes and induced by S. aureus infection, promotes atopic dermatitis-like inflammation by enhancing a type 2 immune response. Credit: Xinm

Updated on:September 04,2024

A year of COVID-19 lockdown is putting kids at risk of allergies, asthma and autoimmune diseases

by Byram W. Bridle,The ConversationCredit: Unsplash/CC0 Public Domain"Eat dirt!" is a phrase I remember well. It was in thetitle of an articlepublished by Harvard Universit

Updated on: May 07,2024

A year of COVID-19 lockdown is putting kids at risk of allergies, asthma and autoimmune diseases

by Byram W. Bridle,The ConversationCredit: Unsplash/CC0 Public Domain"Eat dirt!" is a phrase I remember well. It was in thetitle of an articlepublished by Harvard Universit

Updated on:May 07,2024

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on: June 17,2024

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on:June 17,2024

Triple contrast method for computed tomography diagnostics of cartilage injuries

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainPost-traumatic osteoarthritis (PTOA) is a joint disease associated with the gradual erosion of cartilage covering the ends of arti

Updated on: May 26,2024

Triple contrast method for computed tomography diagnostics of cartilage injuries

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainPost-traumatic osteoarthritis (PTOA) is a joint disease associated with the gradual erosion of cartilage covering the ends of arti

Updated on:May 26,2024